Forecast of Global Growth in Antipsychotic Drugs Market By 2021 June 2017

Global Antipsychotic Drugs Market 2017-2021 Global Antipsychotic Drugs Market report covers the present scenario and the growth prospects of the industry for 2017-2021. To calculate the market size, the report considers sales from both branded and generic drugs. The analysts forecast global Antipsychotic Drugs market to grow at a CAGR of 1.84% during the period 2017-2021. Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of schizophrenic patients. Inquire Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=1041437 Key vendors The key players in the Antipsychotic Drugs Market are AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson. Other Prominent Vendors Other Prominent Vendors in the market are Actavis Generics (a subsidiary of Teva Pharmaceutical Industries), Alkermes, Bristol-Myers Squibb. Purchase Report Directly @ http://www.reportsnreports.com/purchase.aspx?name=1041437 Market driver Increasing expenditure on prescription drugs. Market challenge Lack of standard diagnostic methods. Market trend Rising public interest toward mental health. The report, Global Antipsychotic Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Complete Report Available @ http://www.reportsnreports.com/reports/1041437-global-antipsychotic- drugs-market-2017-2021.html